Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Cotranslational Protein Expression System for High-throughput Screening
Case ID:
TAB-2608
Web Published:
12/6/2022
Reporter gene-based assays are used extensively in high-throughput screening (HTS) to identify chemical modulators of cellular pathways for drug discovery and development. However, such screening frequently results in a large number of false “hits” due to interactions of screened compounds with reporter proteins, producing confounding results. Thus, validation of results using these assays often involves significant time and expense.
The inventors have developed an assay system that significantly improves detection of target-relevant active compounds by discriminating between signals arising from the target activity and those caused by reporter bias. This system utilizes simultaneous detection (also known as “coincidence detection”) of non-homologous reporter proteins with dissimilar properties, such as differing catalysis, light emission, or fluorescence characteristics; simultaneous observation of signals from these reporters indicates a high probability that it is a true target response. The reporters are cotranslationally expressed from a single RNA transcript, which ensures stable stoichiometry of the expressed proteins.
Patent Information:
Title
App Type
Country
Serial No.
Patent No.
File Date
Issued Date
Expire Date
Direct Link:
https://canberra-ip.technologypublisher.com/tech/Cotranslational_Protein_Expr ession_System_for_High-throughput_Screening
Keywords:
AC4XXX
ACXXXX
AXXXXX
Coincidence
drug discovery
Drug Screening
High-throughput
High-throughput screen
HTS
REPORTER
reporter gene
Bookmark this page
Download as PDF
For Information, Contact:
Ami Gadhia
Senior Technology and Patent Specialist
NIH Technology Transfer
301-827-7159
ami.gadhia@nih.gov